Relationship of concomitant anti-diabetic drug administration with sodium-glucose co-transporter 2 inhibitor-related ketosis

OBJECTIVE: The use of sodium-glucose co-transporter 2 inhibitors (SGLT2is) may be associated with ketoacidosis. Therefore, the associated risk factors should be identified. In particular, information regarding the effects of the co-administration of anti-diabetic drugs is lacking. METHODS: We perfor...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Cheng-Wei, Hung, Shih-Yuan, Chen, I-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973047/
https://www.ncbi.nlm.nih.gov/pubmed/35352579
http://dx.doi.org/10.1177/03000605221090095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973047/
https://www.ncbi.nlm.nih.gov/pubmed/35352579
http://dx.doi.org/10.1177/03000605221090095

Ejemplares similares